Amalgamated Bank Enanta Pharmaceuticals Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 667 shares of ENTA stock, worth $6,229. This represents 0.0% of its overall portfolio holdings.

Number of Shares

667

Previous 667 -0.0%

Holding current value

$6,229

Previous $9,000 22.22%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$10.08 - $17.46 $12,176 - $21,091	-1,208 Reduced 64.43%	667 $12,000
Q4 2023 Feb 06, 2024	SELL	$8.18 - $10.78 $1,619 - $2,134	-198 Reduced 9.55%	1,875 $18,000
Q3 2023 Nov 08, 2023	SELL	$11.09 - $22.13 $61,715 - $123,153	-5,565 Reduced 72.86%	2,073 $23,000
Q2 2023 Aug 11, 2023	SELL	$20.68 - $39.85 $13,359 - $25,743	-646 Reduced 7.8%	7,638 $163,000
Q1 2023 May 02, 2023	SELL	$38.82 - $54.59 $23,175 - $32,590	-597 Reduced 6.72%	8,284 $335,000
Q3 2022 Nov 09, 2022	BUY	$48.29 - $71.27 $19,267 - $28,436	399 Added 4.7%	8,881 $461,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $3,279 - $6,615	86 Added 1.02%	8,482 $401,000
Q1 2022 Jun 30, 2022	SELL	$56.06 - $74.11 $19,733 - $26,086	-352 Reduced 4.02%	8,396 $598,000
Q4 2021 Feb 15, 2022	SELL	$60.19 - $97.37 $15,408 - $24,926	-256 Reduced 2.84%	8,748 $654,000
Q3 2021 Oct 29, 2021	SELL	$41.02 - $58.65 $6,111 - $8,738	-149 Reduced 1.63%	9,004 $512,000
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $400,535 - $486,115	9,153 New	9,153 $403,000
Q1 2020 May 13, 2020	SELL	$40.22 - $62.0 $134,656 - $207,576	-3,348 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$57.95 - $66.61 $194,016 - $223,010	3,348 New	3,348 $207,000
Q3 2019 Nov 13, 2019	SELL	$60.08 - $88.17 $193,938 - $284,612	-3,228 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $39,999 - $47,896	492 Added 17.98%	3,228 $272,000
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $189,002 - $289,085	2,736 New	2,736 $261,000
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $231,938 - $342,968	-2,714 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$81.85 - $120.51 $222,140 - $327,064	2,714 New	2,714 $315,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Enanta Pharmaceuticals Inc Transaction History